As your go-to partner for cardiometabolic risk reduction research, industry news, and practical strategies, weve created this highly practical guide to help you educate patients on safe access to GLP-1 RAs for weight loss
sjad211 Chiappini S, Vickers-Smith R, Harris D, Papanti Pelletier GD, Corkery JM, Guirguis A et al (2023) Is there a risk for semaglutide misuse
Final Verdict Inno Shred GLP-1 is packaged like a breakthrough, but at the end of the day, it is still just a supplement, not a real replacement for GLP-1 medication
The peptide precursor of liraglutide, produced by a process that includes expression of recombinant DNA in Saccharomyces cerevisiae, has been engineered to be 97% homologous to native human GLP-1 by substituting arginine for lysine at position 34
HRAs are funded entirely by your employer and governed by an employer-written plan document that can exclude weight-loss medications, require prior approval, or demand a Letter of Medical Necessity (LMN) before reimbursement